July 14, 2016

‘X-Chem’ Marks the Spot for Bayer in Sweetened Drug Discovery Deal

JULY 13, 2016|BIOWORLD TODAY|”‘X-Chem’ Marks the Spot for Bayer in Sweetened Drug Discovery Deal”

Bayer AG and privately held X-Chem Inc. expanded their global drug discovery collaboration, initiated in 2012, to encompass the entire bandwidth of therapeutic areas and target classes from Bayer’s R&D pipeline.

[Read full article]